Dianthus Therapeutics
DNTH
DNTH
102 hedge funds and large institutions have $729M invested in Dianthus Therapeutics in 2025 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 29 increasing their positions, 40 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
4% more funds holding
Funds holding: 98 → 102 (+4)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
28% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 40
Holders
102
Holding in Top 10
6
Calls
$2.68M
Puts
$572K
Top Buyers
| 1 | +$27.9M | |
| 2 | +$14.7M | |
| 3 | +$6.28M | |
| 4 |
Goldman Sachs
New York
|
+$5.42M |
| 5 |
Millennium Management
New York
|
+$3.64M |
Top Sellers
| 1 | -$13.9M | |
| 2 | -$13.7M | |
| 3 | -$6.81M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$4.99M |
| 5 |
BlackRock
New York
|
-$4.79M |
